{"id":"https://openalex.org/W2017436619","doi":"https://doi.org/10.1038/nrd703","title":"Strategies in the design of antiviral drugs","display_name":"Strategies in the design of antiviral drugs","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2017436619","doi":"https://doi.org/10.1038/nrd703","mag":"2017436619","pmid":"https://pubmed.ncbi.nlm.nih.gov/12119605"},"language":"en","primary_location":{"id":"doi:10.1038/nrd703","doi":"https://doi.org/10.1038/nrd703","is_oa":false,"landing_page_url":"https://doi.org/10.1038/nrd703","pdf_url":null,"source":{"id":"https://openalex.org/S186543748","display_name":"Nature Reviews Drug Discovery","issn_l":"1474-1776","issn":["1474-1776","1474-1784"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Drug Discovery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017436619"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040662398","display_name":"Erik De Clercq","orcid":"https://orcid.org/0000-0002-2985-8890","observed_orcids":["https://orcid.org/0000-0002-2985-8890"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Erik De Clercq","raw_affiliation_strings":["Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium. erik.declercq@rega.kuleuven.ac.be","Rega Institute for Medical Research, Katholieke Universiteit Leuven,#R#Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium. erik.declercq@rega.kuleuven.ac.be","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]},{"raw_affiliation_string":"Rega Institute for Medical Research, Katholieke Universiteit Leuven,#R#Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5040662398"],"corresponding_institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"],"apc_list":null,"apc_paid":null,"fwci":7.2036,"has_fulltext":false,"cited_by_count":670,"citation_normalized_percentile":{"value":0.99498328,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"1","issue":"1","first_page":"13","last_page":"25"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.4702000021934509,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.4702000021934509,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.13109999895095825,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.10989999771118164,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiviral-drug-design","display_name":"antiviral drug design","score":0.9700000286102295},{"id":"https://openalex.org/keywords/antiviral-drug-discovery","display_name":"antiviral drug discovery","score":0.8519999980926514},{"id":"https://openalex.org/keywords/viral-life-cycle","display_name":"viral life cycle","score":0.9010000228881836},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.7310000061988831},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.7739999890327454},{"id":"https://openalex.org/keywords/viral-infection","display_name":"viral infection","score":0.8510000109672546},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6060000061988831},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.35199999809265137}],"concepts":[{"id":"https://openalex.org/C2779756493","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral drug","level":3,"score":0.6633497476577759},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6063473224639893},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5848217010498047},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5784472227096558},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5016264915466309},{"id":"https://openalex.org/C2993512173","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral therapy","level":4,"score":0.47369977831840515},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.46772778034210205},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.44874662160873413},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.44377627968788147},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35358795523643494},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.35025233030319214},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2989085018634796},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23332059383392334},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.22549787163734436},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000327","descriptor_name":"Adsorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004279","descriptor_name":"DNA, Viral","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006867","descriptor_name":"Hydrolases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D007168","descriptor_name":"IMP Dehydrogenase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D008561","descriptor_name":"Membrane Fusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009439","descriptor_name":"Neuraminidase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D043383","descriptor_name":"Adenosylhomocysteinase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/nrd703","doi":"https://doi.org/10.1038/nrd703","is_oa":false,"landing_page_url":"https://doi.org/10.1038/nrd703","pdf_url":null,"source":{"id":"https://openalex.org/S186543748","display_name":"Nature Reviews Drug Discovery","issn_l":"1474-1776","issn":["1474-1776","1474-1784"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Drug Discovery","raw_type":"journal-article"},{"id":"pmid:12119605","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12119605","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature reviews. Drug discovery","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":96,"referenced_works":["https://openalex.org/W1515293536","https://openalex.org/W1851303894","https://openalex.org/W1927934418","https://openalex.org/W1958554861","https://openalex.org/W1963535341","https://openalex.org/W1966272651","https://openalex.org/W1966423679","https://openalex.org/W1969114156","https://openalex.org/W1970988101","https://openalex.org/W1972241043","https://openalex.org/W1978333379","https://openalex.org/W1982040698","https://openalex.org/W1982110354","https://openalex.org/W1987702283","https://openalex.org/W1996587882","https://openalex.org/W2001371234","https://openalex.org/W2003926950","https://openalex.org/W2004032126","https://openalex.org/W2012735516","https://openalex.org/W2013670635","https://openalex.org/W2019549077","https://openalex.org/W2020027089","https://openalex.org/W2021799434","https://openalex.org/W2025534990","https://openalex.org/W2026990096","https://openalex.org/W2029523903","https://openalex.org/W2033757712","https://openalex.org/W2044004371","https://openalex.org/W2046653072","https://openalex.org/W2052990805","https://openalex.org/W2057633014","https://openalex.org/W2058524504","https://openalex.org/W2058705907","https://openalex.org/W2060335625","https://openalex.org/W2065760185","https://openalex.org/W2066429701","https://openalex.org/W2069501700","https://openalex.org/W2070707998","https://openalex.org/W2072658090","https://openalex.org/W2075009216","https://openalex.org/W2076001497","https://openalex.org/W2077610561","https://openalex.org/W2078937924","https://openalex.org/W2083950387","https://openalex.org/W2086358466","https://openalex.org/W2086743450","https://openalex.org/W2091840882","https://openalex.org/W2096950500","https://openalex.org/W2098554674","https://openalex.org/W2106571163","https://openalex.org/W2111773881","https://openalex.org/W2112354998","https://openalex.org/W2115002571","https://openalex.org/W2117784959","https://openalex.org/W2120348672","https://openalex.org/W2121706409","https://openalex.org/W2122072514","https://openalex.org/W2123946977","https://openalex.org/W2126383827","https://openalex.org/W2126938335","https://openalex.org/W2127003607","https://openalex.org/W2132462712","https://openalex.org/W2132657130","https://openalex.org/W2135739941","https://openalex.org/W2136685402","https://openalex.org/W2136999196","https://openalex.org/W2137179268","https://openalex.org/W2140478082","https://openalex.org/W2142501479","https://openalex.org/W2142655367","https://openalex.org/W2144529619","https://openalex.org/W2146938237","https://openalex.org/W2147347134","https://openalex.org/W2148625579","https://openalex.org/W2150047295","https://openalex.org/W2151174475","https://openalex.org/W2153918414","https://openalex.org/W2154441401","https://openalex.org/W2154801452","https://openalex.org/W2158021717","https://openalex.org/W2159582645","https://openalex.org/W2171298763","https://openalex.org/W2171711893","https://openalex.org/W2179482622","https://openalex.org/W2181371485","https://openalex.org/W2184573054","https://openalex.org/W2282447175","https://openalex.org/W2305199251","https://openalex.org/W2329251311","https://openalex.org/W2329745947","https://openalex.org/W2334261876","https://openalex.org/W2340606985","https://openalex.org/W2413608660","https://openalex.org/W2413846099","https://openalex.org/W4247370221","https://openalex.org/W4320995993"],"related_works":["https://openalex.org/W4391251955","https://openalex.org/W2188677983","https://openalex.org/W1530327801","https://openalex.org/W2129978084","https://openalex.org/W4232837265","https://openalex.org/W2800221771","https://openalex.org/W7155653165","https://openalex.org/W2736506100","https://openalex.org/W2385937957","https://openalex.org/W2052850399"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":22},{"year":2024,"cited_by_count":26},{"year":2023,"cited_by_count":27},{"year":2022,"cited_by_count":22},{"year":2021,"cited_by_count":30},{"year":2020,"cited_by_count":31},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":26},{"year":2017,"cited_by_count":19},{"year":2016,"cited_by_count":20},{"year":2015,"cited_by_count":26},{"year":2014,"cited_by_count":34},{"year":2013,"cited_by_count":34},{"year":2012,"cited_by_count":23}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}